Chaparro María, Gisbert Javier P
Servicio de Aparato Digestivo, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IP), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, España.
Gastroenterol Hepatol. 2011 Dec;34 Suppl 3:30-5. doi: 10.1016/S0210-5705(11)70096-6. Epub 2014 Oct 30.
Thiopurine agents have been shown to be effective in maintaining remission in patients with Crohn's disease. There is less evidence for the efficacy of these treatments in ulcerative colitis. Consequently, the effect of thiopurines in the latter disease continues to be the subject of debate and controversy remains on whether these drugs are equally effective in both diseases. The present article aims to review, from a practical point of view, the evidence of the efficacy of thiopurines in ulcerative colitis, current indications for this treatment, safety in patients with inflammatory bowel disease and the treatment optimization strategies proposed.
硫嘌呤类药物已被证明对维持克罗恩病患者的缓解有效。这些治疗方法在溃疡性结肠炎中的疗效证据较少。因此,硫嘌呤类药物在后者疾病中的作用仍存在争议,关于这些药物在两种疾病中是否同样有效也存在争议。本文旨在从实际角度回顾硫嘌呤类药物在溃疡性结肠炎中的疗效证据、该治疗的当前适应症、炎症性肠病患者的安全性以及提出的治疗优化策略。